Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 3, 2006, Pages 416-423

  Baklanov, D V ^a   Moodie, K M ^a   McCarthy, F E ^a   Mandrusov, E ^b   Chiu, J ^b   Aswonge, G ^b   Cheng, J ^b   Chow, M ^b   Simons, M ^a   De Muinck, Ebo D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Microspheres; Myocardial infarction; Myocardial uptake; Percutaneous cardiac intervention

Indexed keywords

RADIOACTIVE MICROSPHERE;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BALLOON OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY VEIN; DEVICE; DRUG DELIVERY SYSTEM; HEART CATHETER; HEART INFARCTION; HISTOPATHOLOGY; INJECTION; MALE; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; PHLEBOGRAPHY; PILOT STUDY; PRESSURE MEASUREMENT; RADIOISOTOPE DISTRIBUTION; REVIEW; STATISTICAL ANALYSIS; SWINE; VASCULAR ACCESS;

ANASTOMOSIS, SURGICAL; ANIMALS; BALLOON OCCLUSION; CONTRAST MEDIA; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOCARDIUM; HEART CATHETERIZATION; HEART SEPTUM; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MICROSPHERES; MYOCARDIAL INFARCTION; PERICARDIUM; PILOT PROJECTS; STROKE VOLUME; SWINE;

EID: 33748307426     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20841     Document Type: Review

References (11)

1. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2003;2:863-871.
2. de Muinck ED, Thompson C, Simons M. Progress and prospects: Cell based regenerative therapy for cardiovascular disease. Gene Ther 2006;13:659-671.
3. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled !rial. Lancet 2006; 367:113-121.
4. de Muinck E, Simons M. Re-evaluating therapeutic neo-vascularization. J Moll Cell Cardiol 2004;36:25-32.
5. Marshall DJ, Pulasis M, Lepore JJ, Leiden JM. Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: An important determinant of the efficiency of cardiovascular gene transfer. Mol Ther 2000;1:423-429.
6. von Degenfeld G, Raake P, Kupatl C, Lebherz C, Hinkel R, Gildehaus FJ, Munzing W, Kranz A. Waltenberger J, Simoes M, Schwaiger M, Thein E, Boekstegers P. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 2003; 42:1120-1128.
7. Raake P, von Degenfeld G, Hinkel R, Vachenauer R, Sandner T, Beller S, Andrees M, Kupatt C, Schuler G, Boekstegers P. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004;44:1124-1129.
8. Price ET, Ikeno F, Fenn RC, Chu P, Lyons JK, Fitzgerald PJ, Yueng AC, Yock PG, Rezaee M. Percutaneous endocardia! versus selective coronary venous catheter delivery: Comparisons of transplant efficiency, distribution, and efficacy in reducing infarct size and improving myocardial function. J Am Coll Cardiol (Suppl 1) 2003:67.
9. Reinhardt CP, Dalhberg S, Tries MA, Marcel R, Leppo JA. Stable labeled microspheres to measure perfusion: Validation of a neutron activation assay technique. Am J Physiol Heart Circ Physiol 2001;280:108-116.
10. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ. Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 2002;55:392-397.
11. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-2516.